HomeBUSINESS
BUSINESS

Genentech Seeks to Block Rituxan Biosimilar Launch in Japan
(Jan.10.2018)

Genentech has filed a patent infringement suit in Japan over Rituxan (rituximab), seeking to block the launch of its biosimilar version being planned for later this month by Sandoz and Kyowa Hakko Kirin, according to Chugai Pharmaceutical, which is assisting the Roche comrade in the case ...
(LOG IN FOR FULL STORY)

News Calendar